Neonatal heart failure and noncompaction/dilated cardiomyopathy from mucopolysaccharidosis. First description in literature
- PMID: 33552908
- PMCID: PMC7851837
- DOI: 10.1016/j.ymgmr.2021.100714
Neonatal heart failure and noncompaction/dilated cardiomyopathy from mucopolysaccharidosis. First description in literature
Abstract
Mucopolysaccharidosis are genetic disorders due to deficiency of lysosomal enzymes, resulting in abnormal glycosaminoglycans accumulation in several tissues. Heart involvement tends to be progressive and worsens with age. We describe the first case of mucopolysaccharidosis type I presenting with noncompaction/dilated-mixed cardiomyopathy and heart failure within neonatal period, which responded successfully to specific metabolic treatment. Cardiac function recovered after enzyme replacement therapy and hematopoietic stem cell transplantation, adding to the existing knowledge of the disease.
Keywords: Cardiac failure; Cardiomyopathy; ERT, Enzyme Replacement Therapy; GAGs, Glycosaminoglycans; HSCT, Hematopoietic Stem Cell Transplantation; Heart failure; LV, Left Ventricular; LVEV, Left Ventricular Ejection Fraction; MPS, Mucopolysaccharidosis; Mucopolysaccharidosis; Neonatal; Noncompaction.
© 2021 The Authors.
Figures
References
-
- Oussoren E., Keulemans J., van Diggelen O.P., Oemardien L.F., Timmermans R.G., van der Ploeg A.T. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients. Mol. Genet. Metab. 2013 Aug;109(4):377–381. - PubMed
-
- Martins A.M., Dualibi A.P., Norato D., Takata E.T., Santos E.S., Valadares E.R. Guidelines for the management of mucopolysaccharidosis type I. J. Pediatr. 2009 Oct;155(4 Suppl):S32–S46. - PubMed
-
- Arbustini E., Favalli V., Narula N., Serio A., Grasso M. Left ventricular noncompaction: A distinct genetic cardiomyopathy? J. Am. Coll. Cardiol. 2016;30;68(9):949–966. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources